secwatch.observer — SEC 8-K summary
======================================

Issuer:     GT Biopharma, Inc. (GTBP)
CIK:        0000109657
Form:       8-K
Filed at:   2026-06-12T20:30:27+00:00
Accession:  0001493152-26-028457
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GT Biopharma reduces stockholder meeting quorum from majority to one-third
--------------------------------------------------------------------------

- Board approved amendment to bylaws effective June 8, 2026.
- Quorum lowered from majority to not less than one-third of outstanding voting shares.
- Change aims to improve meeting attendance amid broker non-voting trends.
- Company is fully remote as of July 1, 2024; no principal executive office.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/109657/000149315226028457/0001493152-26-028457-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/109657/000149315226028457/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-028457

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer